Delivery Order 36F79718D0414-36C77021N0218
Award Date 9/8/21
Potential Completion Date 9/30/21
Potential Value $678K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92130, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration awarded a $576,116 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Neurocrine Biosciences, Inc. to provide valbenazine. The contract has a period of performance from March 26, 2020 through April 1, 2020 for product delivery to a location in San Diego, California. Valbenazine will support the VA-VHA's mission to provide healthcare services to veterans through its Veterans Integrated Service Network...
- The Department of Veterans Affairs Veterans Health Administration awarded a $536,349 delivery order to Neurocrine Biosciences, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The order calls for Neurocrine to provide the drug valbenazine to VHA facilities in San Diego, California from February 27 to March 3, 2020. Valbenazine will support VHA's efforts to treat veterans through its Veterans Integrated Service Network 12 program. As a firm fixed price order placed...
- The Department of Veterans Affairs Veterans Health Administration awarded a $676,204.80 firm fixed price delivery order to Neurocrine Biosciences, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The contract calls for Neurocrine to provide valbenazine to Veterans Integrated Service Network 12 in support of the VA-VHA's healthcare programs. Performance will take place in San Diego, California over a period of four days from October 8-12, 2020. No subcontractors or set...
- The Department of Veterans Affairs Veterans Health Administration awarded Neurocrine Biosciences, Inc. a $608,584.32 firm fixed price delivery order against the company's GSA Schedule Pharmaceuticals and Drugs contract. The delivery order, which runs from August 25-27, 2020, is for the drug valbenazine and will support the VA-VHA's Veterans Integrated Service Network 12 located in San Diego, California. Valbenazine is used to treat tardive dyskinesia, an involuntary movement disorder...
- The Department of Veterans Affairs Veterans Health Administration awarded a $677,546 firm fixed price delivery order against the Pharmaceuticals and Drugs GSA Schedule to Neurocrine Biosciences, Inc. to provide valbenazine for Veterans Integrated Service Network 12. Valbenazine will be delivered to support VA-VHA programs in San Diego, California between June 23 and June 30, 2020. No subcontractors or set aside designations were identified. This order enables the VA medical center in San Diego...
- The Department of Veterans Affairs Veterans Health Administration awarded a $677,821.50 firm fixed price delivery order against the prime contractor Neurocrine Biosciences, Inc.'s Pharmaceuticals and Drugs GSA Schedule. This order is for the delivery of VALBENAZINE 80MG and 40MG oral capsules to facilities within Veterans Integrated Service Network 12. Neurocrine Biosciences will deliver the requested medications from its production location in San Diego, California by July 6, 2021 to support...
- The Department of Veterans Affairs Veterans Health Administration awarded Neurocrine Biosciences, Inc. a $674,516 firm fixed price delivery order against the company's Pharmaceuticals and Drugs GSA Schedule contract to provide valbenazine 80mg oral capsules for the Hines CMOP in Illinois. Valbenazine is used to treat tardive dyskinesia. Performance will take place in San Diego, California from September 10-15, 2021. No subcontractors or set aside designations were identified. This order supports...
- The Department of Veterans Affairs Veterans Health Administration awarded a $840,641 delivery order to Neurocrine Biosciences, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The contract calls for Neurocrine to provide VALBENAZINE to Veterans Integrated Service Network 12 in support of VA-VHA programs. Performance will take place in San Diego, California over a period of one week from January 3-10, 2020. The firm fixed price contract utilizes Neurocrine's existing...
- The Department of Veterans Affairs Veterans Health Administration awarded Neurocrine Biosciences, Inc. a $579,765.60 firm fixed price delivery order against the company's GSA Schedule Pharmaceuticals and Drugs contract. The contract calls for Neurocrine to provide VALBENAZINE to Veterans Integrated Service Network 12 in support of the VA-VHA's healthcare programs. Performance will take place in San Diego, California over a one week period in June 2020. No subcontractors or set aside designations...
- This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Neurocrine Biosciences, Inc., a biopharmaceutical company, to provide VALBENAZINE capsules. The contract is issued against Neurocrine's General Services Administration (GSA) Multiple Award Schedule Pharmaceuticals and Drugs contract, with a potential value of $217,459.20. There was no set-aside designation for this award. Neurocrine has provided...